COGNICURRENT

Concerns are rising about severe adverse effects linked to weight loss injections, particularly regarding cases of acute pancreatitis.

Recent discussions about the safety of weight loss medications, particularly GLP-1 receptor agonists like Wegovy and Ozempic, have emerged due to reports of pancreatitis in some users, prompting experts to clarify the actual risks involved.

An 88-year-old woman in Finland waited for death for over eight months due to a misdiagnosis of pancreatic cancer, which was later revealed to be chronic pancreatitis.

A complex surgery successfully removed more than 15 stones from a 36-year-old woman's pancreas at BMHRC, with some stones being as large as 2 cm.

Brazil's health regulatory agency Anvisa has issued a warning about the risks associated with improperly using weight loss pens, including acute pancreatitis, which can be fatal.

Brazil's health agency Anvisa has issued a warning regarding the misuse of weight loss pens, highlighting a link to acute pancreatitis.

Brazil's health agency issues a warning about the risk of pancreatitis associated with GLP-1 agonist medications, also known as weight loss pens, following reports of suspected deaths.

Brazil's Federal Police report that Amapá's pension fund opted for Master over top-tier banks despite warnings, amidst a backdrop of 1.6 million child labor cases and concerns over the health risks of weight loss pens.

Anvisa has issued a warning about the risks associated with the use of weight-loss pens after an investigation into pancreatitis cases linked to their usage found suspicious fatalities in Brazil.

Brazil's health regulatory agency, Anvisa, has issued a warning regarding the dangerous use of weight-loss pens, citing potential health risks including severe pancreatitis and death.

ANVISA issues a warning after a rise in pancreatitis notifications related to weight loss pens.

Anvisa has issued a warning following a spike in pancreatitis notifications related to weight loss pens.

ANVISA has issued a warning following an increase in pancreatitis notifications linked to weight loss pens, while Brazil is investigating six deaths associated with the medication.

Anvisa has issued an alert about the risk of pancreatitis linked to the use of weight loss pens, following reports of six deaths associated with GLP-1 receptor antagonists.

Brazil's health agency Anvisa warns against the use of weight loss pens for obesity and diabetes treatment without medical oversight due to rising cases of pancreatitis.

Experts state that cases of pancreatitis linked to GLP-1 agonists used for diabetes and obesity are uncommon and should not cause alarm.

The article covers various news highlights including Trump criticizing Bad Bunny's Super Bowl performance, a lawyer sharing her story of survival, unfulfilled hospital promises, comments from the newly elected president, student reports of chlorine smell at a pool incident, information on pancreatitis deaths, and reactions to a teenager's death case.

The program 'Bom Dia PE' features a range of news stories including Trump criticizing Bad Bunny for his Super Bowl performance, a lawyer sharing a personal survival story, promises of hospital constructions by Ibaneis, presidential remarks on democracy, student testimonies regarding a pool incident in São Paulo, a report on pancreatitis deaths, and a denial from the mother of a teenager regarding evidence in a case.

Brazil is investigating six deaths due to pancreatitis linked to the use of weight-loss pens, with major brands involved and concerns over counterfeit products.

Pancreatitis cases associated with weight loss pens have surged in Brazil, prompting alerts as the issue gains international attention following a warning from the UK.

Brazil's health regulatory agency Anvisa has reported six suspected deaths related to pancreatitis connected to weight loss pens used from 2020 to 2025.

The Brazilian health authority, Anvisa, has reported six suspected deaths and 225 cases of pancreatitis linked to weight loss pens since 2018, prompting discussions about their safety.

Health authorities have issued a warning to users of weight loss medications like Mounjaro, Ozempic, and Wegovy due to reports of acute and chronic pancreatitis despite the lack of official confirmation linking these drugs to pancreatic inflammation.

The UK Medicines and Healthcare products Regulatory Agency has warned of deaths linked to severe pancreatitis associated with weight-loss and diabetes medications such as Mounjaro and Wegovy, advising users to watch for intense and persistent abdominal pain.

Users of weight loss pens, such as Mounjaro or Wegovy, should be aware of the rare but real possibility of developing acute pancreatitis, according to a warning from the UK's Medicines and Healthcare products Regulatory Agency (MHRA).